Acute hepatitis associated with Barakol

Journal of the Medical Association of Thailand

Volumn 86, Issue SUPPL. 2, 2003, Pages

  Hongsirinirachorn, Mongkon ^a   Threeprasertsuk, Sombat ^b   Chutaputti, Anuchit ^a  

^a PHRAMONGKUTKLAO HOSPITAL   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Barakol; Hepatitis

Indexed keywords

AMINOTRANSFERASE; ANXIOLYTIC AGENT; BARAKOL; BILIRUBIN; UNCLASSIFIED DRUG;

ACUTE HEPATITIS; ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ANAMNESIS; ANOREXIA; ARTHRALGIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DRUG WITHDRAWAL; EOSINOPHILIA; FATIGUE; FEMALE; FEVER; HUMAN; HUMAN TISSUE; INSOMNIA; JAUNDICE; LIVER BIOPSY; LIVER FUNCTION TEST; MALE; NAUSEA; RASH; THAILAND; TRANSAMINITIS; VOMITING;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; BENZOPYRANS; FEMALE; HEPATITIS, TOXIC; HUMANS; MALE; MIDDLE AGED; PHENALENES; RETROSPECTIVE STUDIES;

EID: 0041429545     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey. JAMA 1998; 280: 1569-75.
2. Jonas WB. Alternative medicine-learning from the past, examining the present, advancing to the future (editorials). JAMA 1998; 280: 1616-7.
3. Khi-lek: Thai herbal medicine. Hhao-Sod Newspaper. March 30, 2000: 28.
4. Themsiriroukula R, King TJ, Wallwork SC, et al. Thai herbal medicine. Bangkok: Siambook and Publication, 1999: 90-1.
5. Hassanali-Walji, Barakol, a novel dioxaphenalene derivative from Cassia siamia. J Chem Soc Chem Commun 1969; 12: 678.
6. Tangsrisamruang P. The Preliminary Extraction of Barakol from Cassia siamea and concentration by pervaporation. A Thesis Submitted in Partial Fulfillment of the Requirements for the Degree of Master of Engineering in Chemical Engineering, Department of Chemical Engineering, Bangkok: Chulalongkorn University 1997.
7. Thongsaad W, Deachapunya C, Pongsakorn S, Boyd EA, Bennett GW, Marsden CA. Role of Barakol as a natural anxiolytic. Phar Biochem Behav 1996; 53: 753-8.
8. Thongsaad W, Pongsakorn S, Sudsuang R, Bennett GW, Kendall DA, Marsden CA. Barakol, a natural anxiolytic, inhibits striatal dopamine release but not uptake in vitro. Eu J Pharmacol 1997; 319: 157-64.
9. Fiorino DF, Treit D, menard J, Lermer L Phillips AG. Is Barakol anxiolytic? Behav Pharmacol 1998; 9: 375-8.
10. Chantarayodha P. The CNS Effect of Barakol. PhD research, Department of Physiology, Bangkok: Faculty of Pharmacy, Chulalongkorn University 1988.
11. Koff RS, Gardner R, Harinasuata U, et al. Profile of hyperbilirubinemia in three hospital-populations, Clin Res 1970; 18: 680.
12. Maria VA, Victorino RM. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology 1997; 26: 664-9.
13. Lewis JH, Zimmerman HJ, Drug-induced liver disease. Med Clin North Am 1989; 73: 775-92.
14. Zimmerman HJ, Ishak KG. General aspects of drug-induced liver disease. Gastroenterol Clin North Am 1995; 24: 739-58.
15. Zimmerman HJ, Maddrey WC. Toxic and drug-induced hepatitis. In Schiff L, Schiff ER (eds): Disease of the Liver, ed 5. Philadelphia: JB Lippincott; 1993: 707-83.
16. st ed, 1996: 571-6.
17. rd ed Philadelphia, W.B. Saunders Company 1996: 962-71.
18. William ML. Drug-induced hepatotoxicity. N Engl J Med 1995; 333: 1118-27.
19. nd ed. Pennsylvania, W.B. Saunders Company 1996: 334-5.
20. Fugh-Berman A. Herb-drug interactions. Lancet 2000; 355: 134-8.
21. Hongsirinirachorn M, Chutaputti A. Hepatitis associated with Anhydrobarakol. Annual meeting of The Royal College of Physician of Thailand 2000: 132.
22. Threeprasertsuk S, Hongsirinirachorn M, Chutaputti A. Hepatitis associated with Barakol. Thai Clinic 2000; 16: 385-90.